经导管动脉硬化栓塞联合口服普萘洛尔治疗婴儿巨大血管瘤

发布时间：2018-07-06 10:00

  本文选题：血管瘤 + 栓塞　； 参考：《中国介入影像与治疗学》2017年10期

【摘要】：目的探讨经导管动脉硬化栓塞(TASE)联合口服普萘洛尔治疗普通婴儿巨大血管瘤的临床疗效与安全性。方法对76例普通婴儿巨大血管瘤患儿行TASE联合口服普萘洛尔治疗,于末次治疗后进行疗效评价,分析并发症发生情况。结果对76例患儿共行TASE共95例次,穿刺技术成功率为100%(95/95)。76例患儿中,Ⅰ级预后6例(6/76,7.90%),Ⅱ级19例(19/76,25.00%),Ⅲ级23例(23/76,30.26%),Ⅳ级28例(28/76,36.84%),总有效率100%(76/76)。随访发现疗效稳定,无严重并发症发生。结论 TASE联合口服普萘洛尔治疗婴儿巨大血管瘤疗效确切,且创伤小、并发症少。
[Abstract]:Objective to evaluate the efficacy and safety of transcatheter arterial embolization (TASE) combined with oral propranolol in the treatment of giant hemangioma in infants. Methods 76 cases of normal infants with giant hemangioma were treated with TASE combined with oral propranolol. Results there were 95 cases of tase in 76 cases. The success rate of puncture technique was 100% (95 / 95) .76 cases, the prognosis of grade 鈪，

本文编号：2102412